Abstract
Polycystic kidney disease (PKD) is a potentially life-threatening disorder that affects both adult and pediatric patients. PKD can be either inherited as a dominant (ADPKD) or a recessive trait (ARPKD) or acquired. The disease is characterized by massive renal enlargement associated with the growth of fluid-filled intrarenal cysts. ADPKD, the most common cystic disease, is caused by mutations at three distinct loci: PKD1, PKD2, and PKD3. The PKD1 locus was mapped to human Chr 16p13.3, and the PKD2 locus was mapped to human Chr 4q21–23. The PKD3 locus has not yet been mapped. PKD1 is the most commonly inherited mutation. Patients with ADPKD develop renal, hepatic, and pancreatic cysts, abdominal and inguinal hernias, heart-valve defects, and aortic and cerebral aneurysms (1). ARPKD is encountered less frequently. PKHD1, a locus on human Chr 6p21-cen that predisposes individuals to develop ARPKD, has been reported. ARPKD patients primarily develop cysts in the collecting ducts, with hepatic fibrosis as an associated extrarenal manifestation (2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Harris, P. C., Ward, C. J., Peral, B., and Hughes, J. (1995) Autosomal dominant polycystic kidney disease: molecular analysis. Hum. Mol. Genet. 4, 1745–1749.
Sessa, A., Meroni, M., Righetti, M., Battini, G., Maglio, A., and Puricelli, S. L. (2001) Autosomal recessive polycystic kidney disease. Contrib. Nephrol. 136, 50–56.
Hughes, J., Ward, C. J., Peral, B., Aspinwall, R., Clark, K., San Millan, J. L., et al. (1995) The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 10, 151–160.
Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S. L., Veldhuisen, B., Saris, J. J., et al. (1996) PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272, 1339–1342.
Ward, C. J., Hogan, M. C., Rossetti, S., Walker, D., Sneddon, T., Wang, X., et al. (2002) The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 30, 259–269.
Peters, D. J. and Breuning, M. H. (2001) Autosomal dominant polycystic kidney disease: modification of disease progression. Lancet 358, 1439–1444.
Zerres, K., Rudnik-Schoneborn, S., Steinkamm, C., Becker, J., and Mucher, G. (1998) Autosomal recessive polycystic kidney disease. J. Mol. Med. 76, 303–309.
McDonald, R. A. and Avner, E. D. (1996) Mouse models of polycystic kidney disease, in Polycystic Kidney Disease (Watson, M.L., and Torres, V.E., eds.), Oxford University Press, Oxford, pp. 63–87.
Schieren, G., Pey, R., Bach, J., Hafner, M., and Gretz, N. (1996) Murine models of polycystic kidney disease. Nephrol. Dial. Transplant. 11 (Suppl. 6), 38–45.
Woo, D. D., Nguyen, D. K., and Khatibi, N., and Olsen, P. (1997) Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice. J. Clin. Invest. 100, 1934–1940.
Iakoubova, O. A., Duskin, H., and Beier, D. R. (1995) Localization of a murine recessive polycystic kidney disease mutation and modifying loci that affect disease severity. Genomics 26, 107–114.
Upadhya, P., Churchill, G., Birkenmeier, E. H., Barker, J. E., and Frankel, W. N. (1999) Genetic modifiers of polycystic kidney disease in intersubspecific KAT2J mutants. Genomics 58, 129–137.
Davisson, M., Guay-Woodford, L., Harris, W., and D’Eustachio, P. (1991) The mouse polycystic kidney disease mutation (cpk) is located on proximal chromosome 12. Genomics 9, 778–781.
Gattone, V. H., MacNaudhton, K. A., and Kraybill, A. L. (1996) Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene. Anat. Rec. 245, 488–499.
Hou, X., Mrug, M., Yoder, B. K., Lefkowitz, E. J., Kremmidiotis, G., D’Eustachio, P., et al. (2002) Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease. J. Clin. Invest. 109, 533–540.16.
Woo, D. D., Miao, S. Y., Pelayo, J. C., and Woolf, A. S. (1994) Taxol inhibits progression of congenital polycystic kidney disease. Nature 368, 750–753.
Nagao, S., Watanabe, T., Ogiso, N., Marunouchi, T., and Takahashi, H. (1995) Genetic mapping of the polycystic kidney gene, pcy, on mouse chromosome 9. Biochem. Genet. 33, 401–412.
Takahashi, H., Calvet, J. P., Dittemore-Hoover, D., Yoshida, K., Grantham, J. J. and Gattone, V. H. (1991) A hereditary model of slowly progressive polycystic kidney disease in the mouse. J. Am. Soc. Nephrol. 1, 980–989.
Nakamura, T., Ebihara, I., Nagaoka, I., Tomino, Y., Nagao, S., Takahashi, H., et al. (1993) Growth factor gene expression in kidney of murine polycystic kidney disease. J. Am. Soc. Nephrol. 3, 1378–1386.
Guay-Woodford, L. M., Bryda, E. C., Christine, B., Lindsey, J. R., Collier, W. R., Avner, E. D., et al. (1996) Evidence that two phenotypically distinct mouse PKD mutations, bpk and jcpk, are allelic. Kidney Int. 50, 1158–1165.
Janaswami, P. M., Birkenmeier, E. H., Cook, S. A., Rowe, L. B., Bronson, R. T., and Davisson, M. T. (1997) Identification and genetic mapping of a new polycystic kidney disease on mouse chromosome 8. Genomics 40, 101–107.
Vogler, C., Homan, S., Pung, A., Thorpe, C., Barker, J., Birkenmeier, E. H., et al. (1999) Clinical and pathologic findings in two new allelic murine models of polycystic kidney disease. J. Am. Soc. Nephrol. 10, 2534–2539.
Upadhya, P., Birkenmeier, E. H., Birkenmeier, C. S., and Barker, J. E. (2000) Mutations in a NIMA-related kinase gene, Nek1, cause pleiotropic effects including a progressive polycystic kidney disease in mice. Proc. Natl. Acad. Sci. USA 97, 217–221.
Atala, A., Freeman, M. R., Mandell, J., and Beier, D. R. (1993) Juvenile cystic kidneys (jck): a new mouse mutation which causes polycystic kidneys. Kidney Int. 43, 1081–1085.
Zeier, M., Pohlmeyer, G., Deerberg, F., Schonherr, R., and Ritz, E. (1994) Progression of renal failure in the Han: SPRD polycystic kidney rat. Nephrol. Dial. Transplant. 9, 1734–1739.
Griffin, M. D., Torres, V. E., and Kumar R. (1997) Cystic kidney diseases. Curr. Opin. Nephrol. Hypertens. 6, 276–283.
Lager, D. J., Qian, Q., Bengal, R. J., Ishibashi, M., and Torres, V. E. (2001) The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease. Kidney Int. 59, 126–36.
Moyer, J. H., Lee-Tischler, M. J., Kwon, Heajoon-Y., Schrick, J. J., Avner, E. D., Sweeney, W. E., et al. (1994) Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science 264, 1329–1333.
Murcia, N. S., Sweeney, W. E., Jr., and Avner, E. D. (1999) New insights into the molecular pathophysiology of polycystic kidney disease. Kidney Int. 55, 1187–1197.
Yoder, B. K., Tousson, A., Millican, L., Wu, J. H., Bugg, C. E. Jr., Schafer, J. A., et al. (2002) Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium. Am. J. Physiol. Renal. Physiol. 282, F541–F552.
Trudel, M., Barisoni, L., Lanoix, J., and D’Agati, V. (1998) Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression. Am. J. Pathol. 152, 219–229.
Veis, D. J., Sorenson, C. M., Shutter, J. R., and Korsmeyer, S. J. (1993) Bcl-2-deficiency mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229–240.
Sorenson, C. M. and Sheibani, N. (2002) Altered regulation of SHP-2 and PTP 1B tyrosine phosphatases in cystic kidneys from bcl-2 −/− mice. Am. J. Physiol. Renal. Physiol. 282, F442–F450.
Somlo, S. and Markowitz, G. S. (2002) The pathogenesis of autosomal dominant polycystic kidney disease: an update. Curr. Opin. Nephrol. Hypertens. 4, 385–394.
Calvet, J. P. and Grantham, J. J. (2001) The genetics and physiology of polycystic kidney disease. Semin. Nephrol. 21, 107–123.
Lu, W., Shen, X., Pavlova, A., Lakkis, M., Ward, C. J., Pritchard, L., et al. (2001) Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum. Mol. Genet. 10, 2385–2396.
Kim, K., Drummond, I., Ibraghimov-Beskrovnaya, O., Klinger, K., and Arnaout, M. A. (2000) Polycystin 1 is required for the structural integrity of blood vessels. Proc. Natl. Acad. Sci. USA 97, 1731–1736.
Lu, W., Fan, X., Basora, N., Babakhanlou, H., Law, T., Rifai, N., et al. (1999) Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat. Genet. 21, 160–161.
Qian, F., Watnick, T. J., Onuchic, L. F., and Germino, G. G. (1996) The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 87, 979–987.
Pritchard, L., Sloane-Stanley, J. A., Sharpe, J. A., Aspinwall, R., Lu, W., Buckle, V., et al. (2000) A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. Hum. Mol. Genet. 9, 2617–2627.
Wu, G., Markowitz, G. S., Li, L., D’Agati, V. D., Factor, S. M., Geng, L., et al. (2000) Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat. Genet. 24, 75–78.
Sullivan, L. P., Wallace, D. P., and Grantham, J. J. (1998) Epithelial transport in polycystic kidney disease. Physiol. Rev. 78, 1165–1191.
Lechner, M. S. and Dressler, G. R. (1997) The molecular basis of embryonic kidney development. Mech. Dev. 62, 105–120.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Upadhya, P. (2003). Models of Polycystic Kidney Disease. In: Goligorsky, M.S. (eds) Renal Disease. Methods in Molecular Medicine™, vol 86. Humana Press. https://doi.org/10.1385/1-59259-392-5:13
Download citation
DOI: https://doi.org/10.1385/1-59259-392-5:13
Publisher Name: Humana Press
Print ISBN: 978-1-58829-134-9
Online ISBN: 978-1-59259-392-7
eBook Packages: Springer Protocols